Results 121 to 130 of about 2,013 (145)
Some of the next articles are maybe not open access.

Indolent systemic mastocytosis: is there a reliable radiographic pattern?

Pediatric Radiology, 2012
A 14-year-old boy undergoing treatment for nephrotic syndrome with steroids and cyclosporine presented with small sclerotic bone lesions in a routine chest radiograph. Similar lesions were found in other bones of the axial and appendicular skeleton. Despite the paucity of clinical symptoms and absence of laboratory data suggesting systemic mastocytosis,
Flávia Silva, Braga   +4 more
openaire   +2 more sources

High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis

Allergy, 2012
AbstractBackground: Indolent systemic mastocytosis (ISM) is a rare disease characterized by accumulation of abnormal mast cells in various tissues, including bone marrow. Symptoms are usually related to release of mast cell mediators. The aims are to establish the prevalence of osteoporotic fractures in ISM and to investigate the association with serum
van der Veer, E.   +4 more
openaire   +2 more sources

Demystifying the diagnostic criteria of indolent systemic mastocytosis

Hematological Oncology, 2021
Federica Irene Grifoni   +11 more
openaire   +2 more sources

INDOLENT SYSTEMIC MASTOCYTOSIS: AN INCIDENTAL DIAGNOSIS

Annals of Allergy, Asthma & Immunology, 2023
A. Khalid   +3 more
openaire   +1 more source

[Indolent systemic mastocytosis : an overview in 2025].

Revue medicale suisse
Mast cells (MC) play an important role in the defense against microbial agents, parasites and venoms. The term mastocytosis encompasses a group of diseases characterized by abnormal MC accumulation, divided into cutaneous and systemic forms. The diagnosis of indolent systemic mastocytosis (ISM) is supported by the presence of MC clusters in bone marrow
Julien, Dereme   +3 more
openaire   +1 more source

Avapritinib for the Treatment of Indolent Systemic Mastocytosis

Clinical Immunology, 2023
Samer Abdelkader, Weyman Lam
openaire   +1 more source

Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet?

Journal of Allergy and Clinical Immunology, 2022
Cem Akin, Michel Arock, Peter Valent
exaly  

INDOLENT SYSTEMIC MASTOCYTOSIS PRESENTING AS AN EXCIPIENT ALLERGY

Annals of Allergy, Asthma & Immunology, 2022
L. Franzblau, D. Khan
openaire   +1 more source

Indolent systemic mastocytosis.

The Israel Medical Association journal : IMAJ, 2010
Sergio, Vano-Galvan   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy